SLRN (acelyrin.com) Bozor qiymatining balans qiymatiga nisbati

Acelyrin, Inc. (SLRN) immun patologiyalariga qarshi kurashish uchun patent himoyasidagi ishlanmalarga tayanadi, garchi klinik sinovlarning noaniqligi va yuqori R&D xarajatlari ma'lum risklarni yuzaga keltirsa-da. Shu bilan birga, mustahkam likvidlik rezervi moliyaviy barqarorlikni kafolatlaydi. GURU.Markets portali ushbu grafikni taqdim etadi, unda narxning buki ko'rsatkichi (P/B) spekulyativ chetga chiqishlarni aniqlashga yordam beradi va 0.56 qiymati ushbu darajani xarakterlaydi.

SLRN ACELYRIN Inc.: Balans qiymatiga nisbatan bozor qiymati 21.02.2024 - 31.05.2025 oraligʻida

Acelyrin Inc. (SLRN) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Acelyrin, Inc.|SLRN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati ACELYRIN, Inc.|SLRN - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati ACELYRIN|SLRN - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati acelyrin.com|SLRN - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Acelyrin, Inc.|SLRN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati ACELYRIN, Inc.|SLRN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ACELYRIN, Inc.
Kompaniyaning dastlabki tahlili:Acelyrin, Inc. - SLRN

Acelyrin, Inc. (SLRN) kompaniyasining yallig'lanish kasalliklarini davolashdagi innovatsion ishlanmalari va ularning patent himoyasi kelgusidagi pul oqimlari uchun potentsialni yaratadi. Ushbu kutishlar mvsbcap_co koeffitsiyenti orqali sof aktivlarni bozor qiymatiga aylantiradi. Ushbu metrika aksiyalar narxining kitob kapitalidan yuqoriligini o'lchab, immaterial aktivlarga bozorning ishonchini aks ettiradi. Bir birlikdan yuqori qiymat intellektual kapitalning yuqori baholanganligini ko'rsatadi. Ushbu ishonchdagi o'zgarish bozor qiymatining kitob qiymatiga nisbati ko'rsatkichining o'zgarishida aks etadi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com (ENTX)|Bozor kapitallashuvining balans qiymatiga nisbati HYFT (MindWalk Holdings Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati ABVC BioPharma Inc. ABVC|CPIX: Bozor kapitallashuvining balans qiymatiga nisbati|QNTM - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati FGEN|TELO (telomirpharma.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Rani Therapeutics Holdings|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|Rallybio Corporation - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti LEXX (lexariabioscience.com)|Bozor qiymatining balans qiymatiga nisbati Pulmatrix, Inc.|Balans qiymatiga nisbatan bozor qiymati Pheton Holdings Limited PTHL|Bozor kapitallashuvining balans qiymatiga nisbati APM (Aptorum)|LYRA: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Impact BioMedical|Kapitallashuvning balans qiymatiga nisbati TNF Pharmaceuticals, Inc.|YCBD - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati painreform.com|CYTO (Altamira Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LIPO (Lipella Pharmaceuticals Inc)|OPTN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Pieris Pharma PIRS|PROC: Bozor kapitallashuvining balans qiymatiga nisbati|petrospharma.com (PTPI) - Kapitallashuvning sof aktivlarga nisbati|Qilian International Holding - Kapitallashuvning sof aktivlarga nisbati|TFFP (TFF Pharmaceuticals Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi